Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC.CSBR · Entity 7013 | Vice President, Finance | July 21, 2016 | September 14, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHAMPIONS ONCOLOGY, INC.
Report date July 21, 2016 · Filed September 14, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $2.10 · Expires 2023-06-23 | Direct | 5,515 |
Reported balance
After 2016-07-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2016-07-21 · Grant · Acquired 5,515 · Balance 5,515 F2: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and May 22, 2015 in exchange for new options having a lower exercise price. F1: Fully vested upon grant. |
| Option to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $2.10 · Expires 2025-05-22 | Direct | 11,251 |
Reported balance
After 2016-07-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2016-07-21 · Grant · Acquired 11,251 · Balance 11,251 F2: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and May 22, 2015 in exchange for new options having a lower exercise price. F1: Fully vested upon grant. |
| Option to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $4.92 · Expires 2023-06-23 | Direct | 0 |
Reported balance
After 2016-07-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2016-07-21 · Disposition to issuer · Disposed 6,154 · Balance 0 F2: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and May 22, 2015 in exchange for new options having a lower exercise price. F1: Fully vested upon grant. |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $6.96 · Expires 2025-05-22 | Direct | 0 |
Reported balance
After 2016-07-21 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2016-07-21 · Disposition to issuer · Disposed 12,500 · Balance 0 F2: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and May 22, 2015 in exchange for new options having a lower exercise price. F1: Fully vested upon grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Fully vested upon grant.
F2: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and May 22, 2015 in exchange for new options having a lower exercise price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 21, 2016 Filed Sep 14, 2016 17:34 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Disposition to issuerCommon Stock · Derivative | 12,500 | Not disclosed Strike: $6.96 | Not disclosed |
DisclosureSEC source: 0001628280-16-019562 · wf-form4_147387447815185.xml · derivative · entry 4 MILLER DAVID BARRY · CIK 0001578847 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2025-05-22 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and May 22, 2015 in exchange for new options having a lower exercise price. F1 · derivative.exercise_date: Fully vested upon grant. Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 17:34 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Disposition to issuerOption to purchase Common Stock · Derivative | 6,154 | Not disclosed Strike: $4.92 | Not disclosed |
DisclosureSEC source: 0001628280-16-019562 · wf-form4_147387447815185.xml · derivative · entry 3 MILLER DAVID BARRY · CIK 0001578847 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,154 shares Expires 2023-06-23 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and May 22, 2015 in exchange for new options having a lower exercise price. F1 · derivative.exercise_date: Fully vested upon grant. Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 17:34 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 11,251 | Not disclosed Strike: $2.10 | Not disclosed |
DisclosureSEC source: 0001628280-16-019562 · wf-form4_147387447815185.xml · derivative · entry 2 MILLER DAVID BARRY · CIK 0001578847 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,251 Underlying: Common Stock · 11,251 shares Expires 2025-05-22 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and May 22, 2015 in exchange for new options having a lower exercise price. F1 · derivative.exercise_date: Fully vested upon grant. Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 17:34 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 5,515 | Not disclosed Strike: $2.10 | Not disclosed |
DisclosureSEC source: 0001628280-16-019562 · wf-form4_147387447815185.xml · derivative · entry 1 MILLER DAVID BARRY · CIK 0001578847 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,515 Underlying: Common Stock · 5,515 shares Expires 2023-06-23 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and May 22, 2015 in exchange for new options having a lower exercise price. F1 · derivative.exercise_date: Fully vested upon grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.